S&P 500: 666.06 -1.5% NASDAQ 100: 597.26 -1.7% Dow Jones: 467.48 -1.5%

Metropolitan Life Insurance Co/Ny - Q4 2025 13F Filings

ME

Metropolitan Life Insurance Co/Ny

CIK: 0000728618
Address: New York New York 200 Park Avenue
$329.67 M
Portfolio Value
11
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 02/12/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025

No buy transactions available for this period

Top Sells

Q4 2025
1. AGG Ishares Core Us Aggregate Bond Etf
−$5.89 M
2. SPY Spdr S&P 500 Etf Trust
−$4.98 M
3. VCSH Vanguard Short-Term Corporate Bond Etf
−$1 M
4. VGSH Vanguard Short-Term Treasury Etf
−$998,410
5. QQQ Invesco Qqq Trust Series I
−$982,896

Asset Allocation

Stocks/ETFs
-3.41%
$329.67 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Metropolitan Life Insurance Co/Ny Q4 2025 Filing Summary

Metropolitan Life Insurance Co/Ny filed its 13F report for Q4 2025 on February 12, 2026. The portfolio totaled 329.67 M reflecting a -3.41% change from the prior quarter, spanning 11 assets. The top 10 holdings comprised 98.7% of the portfolio. No significant position changes were reported during the quarter.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Metropolitan Life Insurance Co/Ny’s Q4 2025 Filing

Metropolitan Life Insurance Co/Ny submitted their Form 13F-HR for the Q4 2025 period on 02/12/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Metropolitan Life Insurance Co/Ny reported a managed portfolio value of 329.67 M, consisting of 11 individual positions.

This page displays the raw filing documents. To see which stocks Metropolitan Life Insurance Co/Ny bought or sold during Q4 2025, please visit Metropolitan Life Insurance Co/Ny's Portfolio Analysis page.